Amgen | A Worldwide Pioneer in Biotechnology

Teneobio Acquisition Adds Talent and New Types of Antibodies to Amgen

Going Beyond Skin Deep When Managing Plaque Psoriasis

New FDA Approval Makes Otezla^® (apremilast) Available to More Patients

Otezla is now the first and only oral treatment approved for adult patients across all severities of plaque psoriasis.

FDA Approves Tezspire^™ (tezepelumab-ekko) in the U.S. for Severe Asthma

Accelerating R&D to Speed Medicines to Patients

Long timelines are not an inherent feature of drug development but a problem that can be solved through innovation. Here's how Amgen is responding to this challenge.

COVID-19 Information Center

Check here for Amgen updates, Amgen product information, public health resources, and other pertinent information related to COVID-19.